Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study
- PMID: 32469253
- PMCID: PMC7382541
- DOI: 10.1161/CIRCULATIONAHA.120.047971
Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study
Abstract
Background: Information on the cardiac manifestations of coronavirus disease 2019 (COVID-19) is scarce. We performed a systematic and comprehensive echocardiographic evaluation of consecutive patients hospitalized with COVID-19 infection.
Methods: One hundred consecutive patients diagnosed with COVID-19 infection underwent complete echocardiographic evaluation within 24 hours of admission and were compared with reference values. Echocardiographic studies included left ventricular (LV) systolic and diastolic function and valve hemodynamics and right ventricular (RV) assessment, as well as lung ultrasound. A second examination was performed in case of clinical deterioration.
Results: Thirty-two patients (32%) had a normal echocardiogram at baseline. The most common cardiac pathology was RV dilatation and dysfunction (observed in 39% of patients), followed by LV diastolic dysfunction (16%) and LV systolic dysfunction (10%). Patients with elevated troponin (20%) or worse clinical condition did not demonstrate any significant difference in LV systolic function compared with patients with normal troponin or better clinical condition, but they had worse RV function. Clinical deterioration occurred in 20% of patients. In these patients, the most common echocardiographic abnormality at follow-up was RV function deterioration (12 patients), followed by LV systolic and diastolic deterioration (in 5 patients). Femoral deep vein thrombosis was diagnosed in 5 of 12 patients with RV failure.
Conclusions: In COVID-19 infection, LV systolic function is preserved in the majority of patients, but LV diastolic function and RV function are impaired. Elevated troponin and poorer clinical grade are associated with worse RV function. In patients presenting with clinical deterioration at follow-up, acute RV dysfunction, with or without deep vein thrombosis, is more common, but acute LV systolic dysfunction was noted in ≈20%.
Keywords: COVID-19; echocardiography; heart ventricles; thromboembolism.
Figures
Comment in
-
Letter by Vazgiourakis et al Regarding Article, "Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study".Circulation. 2021 Mar 2;143(9):e749-e750. doi: 10.1161/CIRCULATIONAHA.120.049322. Epub 2021 Mar 1. Circulation. 2021. PMID: 33646831 Free PMC article. No abstract available.
-
Letter by Carrizales-Sepúlveda et al Regarding Article, "Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study".Circulation. 2021 Mar 2;143(9):e751-e752. doi: 10.1161/CIRCULATIONAHA.120.049435. Epub 2021 Mar 1. Circulation. 2021. PMID: 33646833 Free PMC article. No abstract available.
Similar articles
-
Cardiologic Manifestations in Omicron-Type Versus Wild-Type COVID-19: A Systematic Echocardiographic Study.J Am Heart Assoc. 2023 Feb 7;12(3):e027188. doi: 10.1161/JAHA.122.027188. Epub 2023 Jan 25. J Am Heart Assoc. 2023. PMID: 36695308 Free PMC article.
-
Characteristics of Cardiac Injury in Critically Ill Patients With Coronavirus Disease 2019.Chest. 2021 May;159(5):1974-1985. doi: 10.1016/j.chest.2020.10.056. Epub 2020 Oct 28. Chest. 2021. PMID: 33129792 Free PMC article.
-
Transthoracic echocardiographic findings in patients admitted with SARS-CoV-2 infection.Echocardiography. 2020 Oct;37(10):1551-1556. doi: 10.1111/echo.14835. Epub 2020 Sep 19. Echocardiography. 2020. PMID: 32949015 Free PMC article.
-
[Non-ischemic ventricular dysfunction in COVID-19 patients: characteristics and implications for cardiac imaging on the basis of current evidence].G Ital Cardiol (Rome). 2020 Oct;21(10):739-749. doi: 10.1714/3431.34196. G Ital Cardiol (Rome). 2020. PMID: 32968306 Review. Italian.
-
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.Dan Med Bull. 2001 Nov;48(4):199-210. Dan Med Bull. 2001. PMID: 11767125 Review.
Cited by
-
Evaluation of cardiac biomarkers among dead and alive COVID-19 patients in Southwest Iran.J Family Med Prim Care. 2024 Sep;13(9):3931-3937. doi: 10.4103/jfmpc.jfmpc_1964_23. Epub 2024 Sep 11. J Family Med Prim Care. 2024. PMID: 39464908 Free PMC article.
-
The association of radiologic right heart strain indices with the severity of pulmonary parenchymal involvement and prognosis in patients with COVID-19.J Cardiovasc Thorac Res. 2024;16(3):171-178. doi: 10.34172/jcvtr.33094. Epub 2024 Sep 20. J Cardiovasc Thorac Res. 2024. PMID: 39430277 Free PMC article.
-
Infiltrating monocytes drive cardiac dysfunction in a cardiomyocyte-restricted mouse model of SARS-CoV-2 infection.J Virol. 2024 Sep 17;98(9):e0117924. doi: 10.1128/jvi.01179-24. Epub 2024 Aug 29. J Virol. 2024. PMID: 39207134
-
The pathological maelstrom of COVID-19 and cardiovascular disease.Nat Cardiovasc Res. 2022 Mar;1(3):200-210. doi: 10.1038/s44161-022-00029-5. Epub 2022 Mar 16. Nat Cardiovasc Res. 2022. PMID: 39195986 Review.
-
Echocardiographic Assessment of Recovered Patients with Mild COVID-19 Infection: A Case-Control Study.J Cardiovasc Echogr. 2024 Apr-Jun;34(2):72-76. doi: 10.4103/jcecho.jcecho_3_24. Epub 2024 Jun 28. J Cardiovasc Echogr. 2024. PMID: 39086699 Free PMC article.
References
-
- Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015281–39.e14doi: 10.1016/j.echo.2014.10.003 - PubMed
-
- Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 20131281810–1852doi: 10.1161/CIR.0b013e31829e8807 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
